{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:25:38Z","timestamp":1791548738461,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71492-2","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T12:02:29Z","timestamp":1725451349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile\u00a0isolates in Israel, 2020\u20132022"],"prefix":"10.1038","volume":"14","author":[{"given":"Orna","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Rohana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Azrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Rainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Nesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orli","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"71492_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40121-021-00417-7","volume":"10","author":"HS Lee","year":"2021","unstructured":"Lee, H. S., Plechot, K., Gohil, S. & Le, J. Clostridium difficile: Diagnosis and the consequence of over diagnosis. Infect. Dis. Ther. 10, 687\u2013697. https:\/\/doi.org\/10.1007\/s40121-021-00417-7 (2021).","journal-title":"Infect. Dis. Ther."},{"key":"71492_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1128\/JCM.05176-11","volume":"50","author":"MC Rea","year":"2012","unstructured":"Rea, M. C. et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J. Clin. Microbiol. 50, 867\u2013875 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"71492_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5223\/kjpgn.2010.13.2.146","volume":"13","author":"HJ Cho","year":"2010","unstructured":"Cho, H. J. et al. Epidemiology and clinical characteristics of Clostridium difficile -associated disease in children: Comparison between community- and hospital-acquired infections. Korean J. Pediatr. Gastroenterol. Nutr. 13, 146 (2010).","journal-title":"Korean J. Pediatr. Gastroenterol. Nutr."},{"key":"71492_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/antibiotics11111464","volume":"11","author":"M Calatayud","year":"2022","unstructured":"Calatayud, M. et al. Long-term lactulose administration improves dysbiosis induced by antibiotic and C. difficile in the PathoGutTM SHIME model. Antibiotics 11, 1464 (2022).","journal-title":"Antibiotics"},{"key":"71492_CR5","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1038\/s41467-022-32086-6","volume":"13","author":"MD Sacco","year":"2022","unstructured":"Sacco, M. D. et al. A unique class of Zn2+-binding serine-based PBPs underlies cephalosporin resistance and sporogenesis in Clostridioides difficile. Nat. Commun. 13, 4370 (2022).","journal-title":"Nat. Commun."},{"key":"71492_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","volume":"27","author":"J van Prehn","year":"2021","unstructured":"van Prehn, J. et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin. Microbiol. Infect. 27, S1\u2013S21. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.038 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"71492_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fcimb.2019.00356","volume":"9","author":"KY Chen","year":"2019","unstructured":"Chen, K. Y. et al. The transcriptional regulator Lrp contributes to toxin expression, sporulation, and swimming motility in Clostridium difficile. Front. Cell Infect. Microbiol. 9, 356 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"71492_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.15562\/bmj.v11i3.3696","volume":"11","author":"NLPH Wedari","year":"2022","unstructured":"Wedari, N. L. P. H., Budayanti, N. N. S. & Darwinata, A. E. Clostridium difficile virulence factors as the cause of antibiotic-associated diarrhea (AAD): A literature review. Bali Med. J. 11, 1277\u20131281. https:\/\/doi.org\/10.15562\/bmj.v11i3.3696 (2022).","journal-title":"Bali Med. J."},{"key":"71492_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.idc.2014.11.004","volume":"29","author":"DN Gerding","year":"2015","unstructured":"Gerding, D. N. & Lessa, F. C. The epidemiology of Clostridium difficile infection inside and outside health care institutions. Infect. Dis. Clin. North Am. 29, 37\u201350. https:\/\/doi.org\/10.1016\/j.idc.2014.11.004 (2015).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"71492_CR10","doi-asserted-by":"publisher","first-page":"e1009348","DOI":"10.1371\/journal.ppat.1009348","volume":"17","author":"LR Frostid","year":"2021","unstructured":"Frostid, L. R., Chengid, J. K. J. & Unnikrishnanid, M. Clostridioides difficile biofilms: A mechanism of persistence in the gut?. PLoS Pathog. 17, e1009348 (2021).","journal-title":"PLoS Pathog."},{"key":"71492_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S7-O34","author":"D Florea","year":"2014","unstructured":"Florea, D. et al. Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infections. BMC Infect. Dis. https:\/\/doi.org\/10.1186\/1471-2334-14-S7-O34 (2014).","journal-title":"BMC Infect. Dis."},{"key":"71492_CR12","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/microorganisms11071752","volume":"11","author":"A Abad-Fau","year":"2023","unstructured":"Abad-Fau, A., Sevilla, E., Mart\u00edn-Burriel, I., Moreno, B. & Bolea, R. Update on commonly used molecular typing methods for Clostridioides difficile. Microorganisms 11, 1752. https:\/\/doi.org\/10.3390\/microorganisms11071752 (2023).","journal-title":"Microorganisms"},{"key":"71492_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1128\/JCM.01796-09","volume":"48","author":"D Griffiths","year":"2010","unstructured":"Griffiths, D. et al. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 48, 770\u2013778 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"71492_CR14","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1128\/JCM.42.6.2609-2617.2004","volume":"42","author":"L Lemee","year":"2004","unstructured":"Lemee, L., Dhalluin, A., Pestel-Caron, M., Lemeland, J. F. & Pons, J. L. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J. Clin. Microbiol. 42, 2609\u20132617 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"71492_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.diagmicrobio.2015.05.015","volume":"83","author":"A Adler","year":"2015","unstructured":"Adler, A. et al. A national survey of the molecular epidemiology of Clostridium difficile in Israel: The dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole. Diagn. Microbiol. Infect. Dis. 83, 21\u201324 (2015).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"71492_CR16","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.3390\/jcm9124099","volume":"9","author":"H Rohana","year":"2020","unstructured":"Rohana, H. et al. Characterization of Clostridioides difficile strains, the disease severity, and the microbial changes they induce. J. Clin. Med. 9, 4099 (2020).","journal-title":"J. Clin. Med."},{"key":"71492_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00791","author":"N Singhal","year":"2015","unstructured":"Singhal, N., Kumar, M., Kanaujia, P. K. & Virdi, J. S. MALDI-TOF mass spectrometry: An emerging technology for microbial identification and diagnosis. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2015.00791 (2015).","journal-title":"Front. Microbiol."},{"key":"71492_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmi.2017.12.005","volume":"24","author":"C Gateau","year":"2018","unstructured":"Gateau, C., Couturier, J., Coia, J. & Barbut, F. How to: Diagnose infection caused by Clostridium difficile. Clin. Microbiol. Infect. 24, 463\u2013468. https:\/\/doi.org\/10.1016\/j.cmi.2017.12.005 (2018).","journal-title":"Clin. Microbiol. Infect."},{"key":"71492_CR19","unstructured":"Biotec SL. CERTEST Clostridium Difficile GDH+Toxin A+B Revision 00 3 CerTest. www.certest.es (2013)."},{"key":"71492_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-329","author":"EN Hammond","year":"2014","unstructured":"Hammond, E. N., Donkor, E. S. & Brown, C. A. Biofilm formation of Clostridium difficile and susceptibility to Manuka Honey. BMC Complement. Altern. Med. https:\/\/doi.org\/10.1186\/1472-6882-14-329 (2014).","journal-title":"BMC Complement. Altern. Med."},{"key":"71492_CR21","doi-asserted-by":"crossref","unstructured":"Stepanovic, S., Vukovic, D., Dakic, I., Savic, B. & Svabic-Vlahovic, M. A Modified Microtiter-Plate Test for Quantification of Staphylococcal Biofilm Formation. Journal of Methods Microbiological Journal of Microbiological Methods vol. 40 www.elsevier.com\/locate\/jmicmeth (2000).","DOI":"10.1016\/S0167-7012(00)00122-6"},{"key":"71492_CR22","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. EUCAST."},{"key":"71492_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.745383","author":"X Meng","year":"2021","unstructured":"Meng, X. et al. Antibiotic resistances and molecular characteristics of Clostridioides difficile in ICUs in a teaching hospital from Central South China. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2021.745383 (2021).","journal-title":"Front. Med."},{"key":"71492_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03539-6","author":"J Czepiel","year":"2019","unstructured":"Czepiel, J. et al. Clostridium difficile infection: Review. Eur. J. Clin. Microbiol. Infect. Dis. https:\/\/doi.org\/10.1007\/s10096-019-03539-6 (2019).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"71492_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1590\/s0004-2803.230302023-36","volume":"60","author":"FAC Carvalho","year":"2023","unstructured":"Carvalho, F. A. C., Silva, R. O. S., Dos Santos, B. M. R. T., Diniz, A. N. & Vilela, E. G. Clinical outcome and severity of Clostridioides (Clostridium) Difficile infection at a tertiary referral hospital in Brazil. Arq. Gastroenterol. 60, 330\u2013338 (2023).","journal-title":"Arq. Gastroenterol."},{"key":"71492_CR26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ajic.2015.04.209","volume":"43","author":"T Gao","year":"2015","unstructured":"Gao, T. et al. Association of Clostridium difficile infection in hospital mortality: A systematic review and meta-analysis. Am. J. Infect. Control 43, 1316\u20131320 (2015).","journal-title":"Am. J. Infect. Control"},{"key":"71492_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s15010-012-0258-1","volume":"40","author":"JM Wenisch","year":"2012","unstructured":"Wenisch, J. M. et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection 40, 479\u2013484 (2012).","journal-title":"Infection"},{"key":"71492_CR28","doi-asserted-by":"publisher","DOI":"10.3201\/eid2806.212262","author":"T Du","year":"2022","unstructured":"Du, T. et al. Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015\u20132019. Emerg. Infect. Dis. https:\/\/doi.org\/10.3201\/eid2806.212262 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"71492_CR29","first-page":"1299","volume":"9","author":"DR Snydman","year":"2022","unstructured":"Snydman, D. R. et al. A US s of Clostridioides difficile associated diarrheal isolates with special reference to ridinilazole: 2020\u20132021. Open Forum Infect Dis 9, 1299 (2022).","journal-title":"Open Forum Infect Dis"},{"key":"71492_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1099\/mic.0.046243-0","volume":"157","author":"P Vohra","year":"2011","unstructured":"Vohra, P. & Poxton, I. R. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 157, 1343\u20131357 (2011).","journal-title":"Microbiology"},{"key":"71492_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1128\/IAI.02955-14","volume":"83","author":"L Furci","year":"2015","unstructured":"Furci, L. et al. New role for human \u03b1-defensin 5 in the fight against hypervirulent Clostridium difficile strains. Infect. Immun. 83, 986\u2013995 (2015).","journal-title":"Infect. Immun."},{"key":"71492_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79123-2","author":"BAP Roxas","year":"2020","unstructured":"Roxas, B. A. P. et al. Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-020-79123-2 (2020).","journal-title":"Sci. Rep."},{"key":"71492_CR33","doi-asserted-by":"publisher","first-page":"102440","DOI":"10.1016\/j.anaerobe.2021.102440","volume":"72","author":"MS Almutairi","year":"2021","unstructured":"Almutairi, M. S. et al. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe 72, 102440 (2021).","journal-title":"Anaerobe"},{"key":"71492_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jiac.2018.03.015","volume":"24","author":"I Tokimatsu","year":"2018","unstructured":"Tokimatsu, I. et al. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan. J. Infect. Chemother. 24, 641\u2013647 (2018).","journal-title":"J. Infect. Chemother."},{"key":"71492_CR35","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.2147\/IDR.S407497","volume":"16","author":"C Shu","year":"2023","unstructured":"Shu, C. et al. Genomic epidemiology and antimicrobial resistance profiles of Clostridioides difficile from multi-hospitals in a City in Eastern China. Infect Drug Resist 16, 3379\u20133388 (2023).","journal-title":"Infect Drug Resist"},{"key":"71492_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ng.2478","volume":"45","author":"M He","year":"2013","unstructured":"He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109\u2013113 (2013).","journal-title":"Nat. Genet."},{"key":"71492_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1323257","author":"O Schwartz","year":"2023","unstructured":"Schwartz, O. et al. Characterization of community-acquired Clostridioides difficile strains in Israel, 2020\u20132022. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1323257 (2023).","journal-title":"Front. Microbiol."},{"key":"71492_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12879-023-08666-2","volume":"23","author":"Y Cui","year":"2023","unstructured":"Cui, Y. et al. An epidemiological surveillance study (2021\u20132022): Detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China. BMC Infect. Dis. 23, 703 (2023).","journal-title":"BMC Infect. Dis."},{"key":"71492_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3855\/jidc.16056","volume":"16","author":"Y Boudjelal","year":"2022","unstructured":"Boudjelal, Y. et al. Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals. J. Infect. Dev. Ctries. 16, 1055\u20131063 (2022).","journal-title":"J. Infect. Dev. Ctries."},{"key":"71492_CR40","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/cid\/ciab549","volume":"73","author":"S Johnson","year":"2021","unstructured":"Johnson, S. et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile infection in adults. Clin. Infect. Dis. 73, 1029\u20131044 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"71492_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings, C. & Riley, T. V. Antibiotics and hospital-acquired Clostridium difficile infection: Update of systematic review and meta-analysis. J. Antimicrob. Chemother. 69, 881\u2013891. https:\/\/doi.org\/10.1093\/jac\/dkt477 (2014).","journal-title":"J. Antimicrob. Chemother."}],"updated-by":[{"DOI":"10.1038\/s41598-024-73686-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71492-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71492-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71492-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:13:16Z","timestamp":1727428396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71492-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71492"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71492-2","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-024-73686-0","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-73686-0","URL":"https:\/\/doi.org\/10.1038\/s41598-024-73686-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20607"}}